| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |